Regulation of activity of the transcription factor GATA-1 by acetylation
The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Modification of histones, DNA-binding proteins found in chromatin, by addition of acetyl groups occurs to a greater degree when the histones are associated with transcriptionally active DNA. A breakthrough in understanding how this acetylation is mediated was the discovery that various transcriptional co-activator proteins have intrinsic histone acetyltransferase activity (for example, Gcn5p, PCAF, TAF(II)250 and p300/CBP. These acetyltransferases also modify certain transcription factors (TFIIEbeta, TFIIF, EKLF and p53). GATA-1 is an important transcription factor in the haematopoietic lineage and is essential for terminal differentiation of erythrocytes and megakaryocytes. It is associated in vivo with the acetyltransferase p300/CBP. Here we report that GATA-1 is acetylated in vitro by p300. This significantly increases the amount of GATA-1 bound to DNA and alters the mobility of GATA-1-DNA complexes, suggestive of a conformational change in GATA-1. GATA-1 is also acetylated in vivo and acetylation directly stimulates GATA-1-dependent transcription. Mutagenesis of important acetylated residues shows that there is a relationship between the acetylation and in vivo function of GATA-1. We propose that acetylation of transcription factors can alter interactions between these factors and DNA and among different transcription factors, and is an integral part of transcription and differentiation processes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“CBP acetylates GATA-1 at two highly conserved lysine-rich motifs near each of the two zinc fingers (10, 27).”
From Inhibition of CBP-Mediated Protein Acetylation by the Ets Family Oncoprotein PU.1 (2002) · cites this paper as [10]
In the citing paper
“The basic tail of the GATA-1 CF has been shown to undergo a number of post-translational modifications.”
From Molecular Analysis of the Interaction between the Hematopoietic Master Transcription Factors GATA-1 and PU.1 (2006) · cites this paper as [34]
Citations
Cites
The Transcriptional Coactivators p300 and CBP Are Histone Acetyltransferases
Ogryzko, V. V., Schiltz, R. L., Russanova, V., Howard, B. H., & Nakatani, Y. (1996) · Cell · doi:10.1016/s0092-8674(00)82001-2 · Cited by 2,952
Self-citationHistone acetylation in chromatin structure and transcription
Grunstein, M. (1997) · Nature · doi:10.1038/38664 · Cited by 2,884 · cited 1×
“gif" NDATA ITEM> ]> Modification of histones, DNA-binding proteins found in chromatin, by addition of acetyl groups occurs to a greater degree when the histones are associated with transcriptionally active DN”
BackgroundActivation of p53 Sequence-Specific DNA Binding by Acetylation of the p53 C-Terminal Domain
Gu, W., & Roeder, R. G. (1997) · Cell · doi:10.1016/s0092-8674(00)80521-8 · Cited by 2,559 · cited 1×
“These acetyltransferases also modify certain transcription factors (TFIIEβ, TFIIF, EKLF and p53”
BackgroundThe CBP co-activator is a histone acetyltransferase
Bannister, A. J., & Kouzarides, T. (1996) · Nature · doi:10.1038/384641a0 · Cited by 1,805
Brownell, J. E., Zhou, J., Ranalli, T., Kobayashi, R., Edmondson, D. G., Roth, S. Y., & Allis, C. D. (1996) · Cell · doi:10.1016/s0092-8674(00)81063-6 · Cited by 1,640 · cited 1×
“A breakthrough in understanding how this acetylation is mediated was the discovery that various transcriptional co-activator proteins have intrinsic histone acetyltransferase activity (for example, Gcn5p”
BackgroundA p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A
Yang, X.-J., Ogryzko, V. V., Nishikawa, J.-I., Howard, B. H., & Nakatani, Y. (1996) · Nature · doi:10.1038/382319a0 · Cited by 1,479
Self-citationPevny, L., Simon, M. C., Robertson, E., Klein, W. H., Tsai, S.-F., D'Agati, V., Orkin, S. H., & Costantini, F. (1991) · Nature · doi:10.1038/349257a0 · Cited by 1,308 · cited 1×
“and is essential for terminal differentiation of erythrocytes and megakaryocyte”
BackgroundA direct link between core histone acetylation and transcriptionally active chromatin.
Hebbes, T. R., Thorne, A. W., & Crane-Robinson, C. (1988) · The EMBO Journal · doi:10.1002/j.1460-2075.1988.tb02956.x · Cited by 923
GATA-binding transcription factors in hematopoietic cells
Orkin, S. (1992) · Blood · doi:10.1182/blood.v80.3.575.575 · Cited by 884 · cited 1×
“GATA-1 is an important transcription factor in the haematopoietic lineag”
BackgroundThe TAFII250 Subunit of TFIID Has Histone Acetyltransferase Activity
Mizzen, C. A., Yang, X.-J., Kokubo, T., Brownell, J. E., Bannister, A. J., Owen-Hughes, T., Workman, J., Wang, L., Berger, S. L., Kouzarides, T., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81821-8 · Cited by 727
Self-citation
Cited by
Items 601–700 of 708
Selective cleavage enhanced by acetylating the side chain of lysine
Fu, L., Chen, T., Xue, G., Zu, L., & Fang, W. (2013) · Journal of Mass Spectrometry · doi:10.1002/jms.3136 · Cited by 6
Microchip-based strategy for enrichment of acetylated proteins
Xu, L., Wang, W., Zhang, Z., Yang, P., Fan, H., & Kong, J. (2013) · Microchimica Acta · doi:10.1007/s00604-013-0950-6 · Cited by 6
Deindl, P., Klar, M., Drews, D., Cremer, M., Gammella, E., Gassmann, M., & Dame, C. (2014) · Haematologica · doi:10.3324/haematol.2014.104844 · Cited by 6
Myb induced myeloid protein 1 (Mim‐1) is an acetyltransferase
Allen, S. C. H., & Hebbes, T. R. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)03803-6 · Cited by 6
Wang, L., Zhou, L., Shu, J., Li, N., Zhang, H., Jin, R., Zhuang, L., & Zhou, G. (2017) · Oncotarget · doi:10.18632/oncotarget.18371 · Cited by 5
“p300 was reported to acetylate GATA-1 within its dual-zinc finger domain and stimulate GATA-1 dependent transcription both in vivo and in vitro [16, 17].”
BackgroundGATA1: function through disorder
Strouboulis, J., & Ronchi, A. E. (2022) · Blood · doi:10.1182/blood.2021015351 · Cited by 5
Bonham-Carter, O., Thapa, I., & Bastola, D. K. (2014) · ACM International Conference on Bioinformatics, Computational Biology, and Health Informatics (ACM-BCB) · doi:10.1145/2649387.2660848 · Cited by 4
“The acetylation of lysine (K) residue is considered as a regulating mechanism for various epigenetic factors [11, 9].”
BackgroundSpecific rearrangement reactions of acetylated lysine containing peptide bn (n = 4–7) ion series
Atik, A. E., Hernandez‐Alba, O., Maître, P., & Yalçın, T. (2014) · Journal of Mass Spectrometry · doi:10.1002/jms.3462 · Cited by 4
Bonham-Carter, O., Thapa, I., From, S. G., & Bastola, D. K. (2016) · Briefings in Bioinformatics · doi:10.1093/bib/bbv111 · Cited by 4
HDAC Inhibitors: An Emerging Anticancer Therapeutic Strategy
Kwon, P. O., Hsu, M., Cohen, D., & Atadja, P. W. (2006) · Humana Press eBooks · doi:10.1385/1-59745-024-3:315 · Cited by 4
Bolger, T. A., Cohen, T., & Yao, T. (2007) · Springer eBooks · doi:10.1007/978-0-387-40049-5_6 · Cited by 4
Implications of transcriptional coactivator CREB binding protein complexes in rheumatoid arthritis
Nakajima, T., Aratani, S., Nakazawa, M., Hirose, T., Fujita, H., & Nishioka, K. (2004) · Modern Rheumatology · doi:10.1007/s10165-003-0258-1 · Cited by 5
Secco, P., Cotella, D., & Santoro, C. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)00897-0 · Cited by 5
Transcription and the Control of Gene Expression
Wiper‐Bergeron, N., & Skerjanc, I. S. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-440-7_2 · Cited by 3
Structural Studies with Coactivators for the Estrogen Receptor
Yi, P., Wang, Z., & O’Malley, B. W. (2018) · Cancer drug discovery and develogment/Cancer drug discovery and development · doi:10.1007/978-3-319-99350-8_4 · Cited by 3
Transcriptional regulation of the human ALDH1A1 promoter by the oncogenic homeoprotein TLX1/HOX11
Rice, K. L., Heidari, M., Taplin, R., Kees, U. R., & Greene, W. K. (2009) · Hematology Reports · doi:10.4081/hr.2009.e13 · Cited by 3
“As is the case for GATA2 and GATA3,(59,60) the DNA binding and transcriptional activity of GATA1 is heavily dependent on its acetylation status.(61) Taken together, we suggest a model in which interactions between TLX1 and both TFIIB and CBP lead to the transcriptional repression observed in our transient luciferase a…”
BackgroundLavender, P., Cousins, D. J., Smith, P., & Lee, T. (2000) · Clinical & Experimental Allergy · doi:10.1046/j.1365-2222.2000.01010.x · Cited by 3
Targeting Histone Deacetylase as a Strategy for Cancer Prevention
Oh, H. J., Chung, E. J., Lee, S., Loaiza‐Perez, A., Sausville, E. A., & Trepel, J. B. (2004) · Humana Press eBooks · doi:10.1007/978-1-59259-767-3_43 · Cited by 3
BHLHE40 Cooperates with GATA2/3 to Control Human Syncytiotrophoblast Lineage Differentiation
Peng, L., Zhao, W., Xu, C., Li, Y., Guo, J., Zhou, T., Chiu, P. C. N., Wu, H., Wu, Q., Wei, Y., et al. (2025) · Advanced Science · doi:10.1002/advs.202507642 · Cited by 2
Ononye, O. E., Surendran, S., Battapadi, T., VanderVere-Carozza, P. S., Howald, O. K., Petrides, A. K., Jordan, M. R., Ainembabazi, D., Wold, M. S., Turchi, J. J., et al. (2025) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2025.110250 · Cited by 2
“This has been observed for various other cellular proteins including p53 (66), E2F1 (67), STAT3 (68), GATA1 transcription factor (69), AP endonuclease (70), p50 and p65 (NF-k B) (71) among many others, where acetylation improves their DNA binding properties.”
Philipsen, S., & Wood, W. G. (2009) · Cambridge University Press eBooks · doi:10.1017/cbo9780511596582.006 · Cited by 2
How signaling pathways interact with gene transcription.
Kagoshima, M., Cosío, B. G., & Adcock, I. M. (2003) · PubMed · Cited by 2
Dynamic regulation of gata factor levels is more important than their identity
Ferreira, R., Wai, A., Shimizu, R., Gillemans, N., Rottier, R. J., Lindern, M. V., Ohneda, K., Grosveld, F. G., Yamamoto, M. P., & Philipsen, S. (2006) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2006.10.117 · Cited by 2
Genetics and Epigenetics in Cancer Biology
Velcich, A., Klampfer, L., Mariadason, J. M., Smartt, H. J. M., Guilmeau, S., Maier, S. M., Yang, W., Christman, J. K., Heerdt, B. G., & Augenlicht, L. H. (2006) · Elsevier eBooks · doi:10.1016/b978-012088393-6/50059-2 · Cited by 2
Histone Modifications as Therapeutic Targets for Cancer
Zhang, L., Wang, T., Geng, S. B., & Ren, K. (2014) · Pharmaceutical and Biosciences Journal · doi:10.20510/ukjpb/2/i2/91156 · Cited by 2
Histone Deacetylase Inhibitors: A Novel Therapeutic Approach for Cognitive Disorders
Labrie, V. (2011) · Springer eBooks · doi:10.1007/978-3-642-17426-1_12 · Cited by 2
“HATinduced acetylation of transcription factors, such as p53, GATA-1, and Myo-D, has been shown to alter their DNA binding affinity and enhance transcription ( Boyes et al. 1998; Gu and Roeder 1997; Polesskaya et al. 2000).”
BackgroundSahakian, E., Woan, K. V., Villagra, A., & Sotomayor, E. M. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-394296-8.00022-1 · Cited by 2
Research progress on histone epigenetic modifications in placental trophoblast syncytialization
Liu, Y., Wang, W., Quan, X., Yang, X., & Zhu, Y.-N. (2026) · Life Sciences · doi:10.1016/j.lfs.2026.124344 · Cited by 1
Ghavidel, P., Abdelmalki, Y., & Sincennes, M. (2026) · Frontiers in Bioscience-Landmark · doi:10.31083/fbl46704 · Cited by 2
Malospirito, C. C., Dias, M. M. G., Jara, G. E., Avelino, T. M., Elias, G. B., de Oliveira, P. S. L., & Figueira, A. C. M. (2026) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.70140 · Cited by 1
“In addition, the p300-pCI vector was a generous gift from Dr. Joan Boyes's group [23], and the pET28a- SMT3- SIRT1-143CS plasmid for bacterial expression was donated by Rui-Ming Xu (Chinese Academy of Sciences, National Laboratory of Biomacromolecules) [24].”
Zhu, W. (2010) · ScholarlyCommons (University of Pennsylvania) · Cited by 1
Schwartz, R. J., Sepulveda, J. L., & Belaguli, N. S. (2002) · Birkhäuser Boston eBooks · doi:10.1007/978-1-4612-0199-1_7 · Cited by 1
Epigenetic Changes and Potential Targets in Pancreatic Cancer
Singh, R., Lillard, J. W., & Singh, S. (2016) · Springer eBooks · doi:10.1007/978-3-319-24951-3_2 · Cited by 1
THE MOLECULAR, CELLULAR, AND GENETIC BASIS OF HEMOGLOBIN DISORDERS
Steinberg, M. H., Forget, B. G., Higgs, D. R., & Weatherall, D. J. (2009) · Cambridge University Press eBooks · doi:10.1017/cbo9780511596582.004 · Cited by 1
The role of GATA-1 isoforms in haematopoiesis
Halsey, C. (2009) · Enlighten: Theses (The University of Glasgow) · Cited by 2
Mapping the Androgen Receptor Cistrome
Wang, Q., & Brown, M. A. (2009) · Springer eBooks · doi:10.1007/978-0-387-69179-4_28 · Cited by 2
Peters (2018) · Digital Repository Service (Northeastern University) · doi:10.17760/d20293303 · Cited by 1
Urnov, F. D., & Wolffe, A. P. (2002) · Elsevier eBooks · doi:10.1016/b978-012174597-4.50005-3 · Cited by 1
Hauschild, K., Carlson, C., Donato, L., Moretti, R., & Ansari, A. (2008) · Wiley eBooks · doi:10.1002/9780470048672.wecb603 · Cited by 1
Differentiation Therapy in AML
Lin, T. L., & Matsui, W. H. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-322-6_14 · Cited by 1
Cell Proliferation: From Signal Transduction to Cell Cycle
Yoshida, M. (2000) · Springer eBooks · doi:10.1007/978-4-431-65927-3_2
Histone Acetyltransferases in Development
Evrard, Y. A., & Dent, S. (2004) · Elsevier eBooks · doi:10.1016/b978-012436643-5/50099-7
Funktionelle Charakterisierung bakterieller Histondeacetylase-ähnlicher Amidohydrolasen (HDAH)
Hildmann, C. (2005) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-609 · Cited by 2
Structure-function analysis of a protein encoded by the BHV-1 latency related gene
Sinani, D. (2012) · Lincoln (University of Nebraska)
Chapter 9 GATA proteins as molecular gatekeepers of adipogenesis
Tsai, J., Tong, Q., & Hotamışlıgil, G. S. (2006) · Advances in molecular and cellular endocrinology · doi:10.1016/s1569-2566(06)05009-5
DNA Fragmentation and Histone Hyperacetylation in the Hypoxic-Acidotic Cardiomyocyte
Thompson, J. W. (2008)
Regulation of YY1, a Multifunctional Transcription Factor
Yao, Y. (2001) · Digital Commons - University of South Florida (University of South Florida)
Gene regulation mechanisms by the transcriptional coregulator mastermind-like 1
Ribeiro, M. S. J. (2009) · Figshare
Estudio ex vivo del papel de GATA-1 en el destino celular de progenitores eritro-megacariocíticos.
Morales, B. (2010) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Methylation Detection and Epigenomics in Pancreatic Cancer
Feldmann, G., & Maitra, A. (2010) · Springer eBooks · doi:10.1007/978-1-4419-1160-5_10
Functional analysis of the von Hippel-Lindau tumour suppressor and its role in tumourigenesis
Barry, R. E. (2004) · edoc (University of Basel) · doi:10.5451/unibas-003376459
“in various proteins, including histones, ERF1, MyoD, GATA-1 and p53 [227-230].”
Kinetic Mechanism and Inhibitory Study of Protein Arginine Methyltransferase 1
Feng, Y. (2012) · Digital Archive @ GSU · doi:10.57709/3006031
Transcriptional Regulation of the E-Selectin Gene
Collins, T., Sheppard, K.-A., Simeonidis, S., & Rose, D. W. (2001) · Springer eBooks · doi:10.1007/978-1-4615-1565-4_2
Zhang, B., Zhao, C., Luo, K., Yan, G., Yao, J., Wang, Y., Lu, H., Fan, H., & Yang, P. (2010) · Science China Chemistry · doi:10.1007/s11426-010-0005-3
INTERPLAY OF EXTRINSIC AND INTRINSIC CUES IN CELL-FATE DECISIONS
Palani, S. (2010) · ScholarlyCommons (University of Pennsylvania)
D-site of albumin promoter binding protein (DBP) may regulate hematopoiesis
Sethunarayanan (2011) · Biology and medicine
EPIGENETIC SILENCING OF THE PROAPOPTOTIC GENE BIM IN ANAPLASTIC
Mogavero, A. (2010)
Cardoso, B. A. (2011) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Regulation of apoptosis by mar binding protein smar1
Sinha, S. (2009) · INFLIBNET
The tip60 HAT-complex is recruited to chromatin by the transcription factors E2F and Myc
Taubert, S. (2003) · reroDoc Digital Library
Liu, T. (2007) · VTechWorks (Virginia Tech)
A molecular ‘switchboard’ : lysine modifications and their impact on transcription.
Zheng, G. (2006) · OhioLink ETD Center (Ohio Library and Information Network)
Molecular determinants of human T cell differentiation and host-pathogen interaction.
Sundrud, M. S. (2005) · Europe PMC (PubMed Central)
Inflammation in Cardiovascular Diseases
Wu, K. K. (2010) · Cambridge University Press eBooks · doi:10.1017/cbo9781139195737.028
Regulation of Nuclear NF-_B Action: A Key Role for Posttranslational Modification
Chen, L., & Greene, W. C. (2006) · CRC Press eBooks · doi:10.1201/9781420004274.ch5
Functional characterization and physiological significance of SETD3
Chia, S. J. (2017) · DR-NTU (Nanyang Technological University) · doi:10.32657/10356/72760
Sarjeant, K. (2011) · Louisiana State University · doi:10.31390/gradschool_theses.573
DNA Methylation and Histone Modifications in Autoimmunity
Banik, D., Chiappinelli, K. B., & Villagra, A. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-809912-4.00003-9
Study of Histone deacetylases (HDAC) as therapeutic targets in gastric cancer
Gries, A. (2018) · theses.fr (ABES) · doi:10.70675/67a8a804z498fz4f71zb93cz97059b36abe6
Ravikumar, V., Anusha, C., & Chidambaram, R. K. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813939-4.00008-5
Molecular regulation of BRD3 in forward programming of Megakaryocytes
Rosa, M. I. (2018) · Apollo (University of Cambridge) · doi:10.17863/cam.39739
The Role of BRDT in Esophageal Squamous Cell Carcinoma
Wang, X. (2021) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-8368
Epigenetic regulation of tumor angiogenesis
Hellebrekers, D. M. E. I. (2006) · Research Publications (Maastricht University) · doi:10.26481/dis.20061102dh
(2002) · Wiley eBooks · doi:10.1002/9780470695975.refs
Sen, R. (2003) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.1015087.195800
Full PDF of Hematology Reviews 2009, volume 1, issue 1.
Editors, T. L. O. (2011) · Hematology Reports · doi:10.4081/1716 · Cited by 1
Gregoricchio, S. (2021) · theses.fr (ABES) · doi:10.70675/f1d71abdzfa19z4e95z89e6zdfa431de5448
O’Mahony, A., Chen, L. F., & Greene, W. C. (2003) · Springer eBooks · doi:10.1007/978-94-010-0163-2_7
Additional file 7 of Alternative TFAP2A isoforms have distinct activities in breast cancer
Berlato, C., Chan, K. V., Price, A. M., Canosa, M., Scibetta, A. G., & Hurst, H. C. (2020) · Figshare · doi:10.6084/m9.figshare.12877498
Additional file 4 of Alternative TFAP2A isoforms have distinct activities in breast cancer
Berlato, C., Chan, K. V., Price, A. M., Canosa, M., Scibetta, A. G., & Hurst, H. C. (2020) · Figshare · doi:10.6084/m9.figshare.12877489
Additional file 1 of Alternative TFAP2A isoforms have distinct activities in breast cancer
Berlato, C., Chan, K. V., Price, A. M., Canosa, M., Scibetta, A. G., & Hurst, H. C. (2020) · Figshare · doi:10.6084/m9.figshare.12877480
Additional file 6 of Alternative TFAP2A isoforms have distinct activities in breast cancer
Berlato, C., Chan, K. V., Price, A. M., Canosa, M., Scibetta, A. G., & Hurst, H. C. (2020) · Figshare · doi:10.6084/m9.figshare.12877495
Additional file 5 of Alternative TFAP2A isoforms have distinct activities in breast cancer
Berlato, C., Chan, K. V., Price, A. M., Canosa, M., Scibetta, A. G., & Hurst, H. C. (2020) · Figshare · doi:10.6084/m9.figshare.12877492
Additional file 3 of Alternative TFAP2A isoforms have distinct activities in breast cancer
Berlato, C., Chan, K. V., Price, A. M., Canosa, M., Scibetta, A. G., & Hurst, H. C. (2020) · Figshare · doi:10.6084/m9.figshare.12877486
Revisiting Mechanisms of Eukaryotic Gene Regulation
Karr, J. P. (2023) · eScholarship (California Digital Library)
Jin, Y., Hasegawa, Y., Zhou, Z., Lin, J. T., Leung, A. K.-Y., Yu, H., & Lis, J. T. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.02.16.706221
“We focused on GATA1, a pioneer factor strongly enriched in the strong enhancers (cluster 7) and essential for enhancer activity in K562 cells 18,46,47 .”
Acetylation modification in malignant progression and therapeutic resistance of gliomas
Zhang, J., Wang, M., Wang, H., Jiang, X., & Zou, H. (2026) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2026.1808361
Neural stem cells plasticity and differentiation
Flici, H. (2012) · theses.fr (ABES) · doi:10.70675/43448416z369fz4b50zb0d2z985989dbb1ed
Molecular Basis of Erythroid Cell Proliferation and Differentiation
Penglong, T. (2015) · theses.fr (ABES) · doi:10.70675/986539e1z7eb6z408fzb159zc7c15d4cefa4
Metadata
- Authors
- Boyes, J., Byfield, P., Nakatani, Y., & Ogryzko, V.
- Affiliations
- Institute of Cancer Research (GB)
- Hammersmith Hospital (GB)
- National Institutes of Health (US)
- Corresponding author
- Boyes, Joan
- Venue
- Nature
- Published
- 1998-12
- Volume
- 396
- Issue
- 6711
- Pages
- 594-598
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1626483287
- Cited by
- 694
- References
- 28
- Citations by year
- 2026: 9 · 2025: 5 · 2024: 4 · 2023: 3 · 2022: 10 · 2021: 9 · 2020: 13 · 2019: 11 · 2018: 10 · 2017: 7 · 2016: 12 · 2015: 7 · 2014: 14 · 2013: 14 · 2012: 15
- FWCI
- 21.11
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Kruppel-like factors research
- Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
- Keywords
- GATA-1, histone acetylation, CBP/p300, transcriptional coactivator, histone acetyltransferase, protein conformational change, erythroid differentiation, acetylation sites
- MeSH terms
- Acetylation, Amino Acid Sequence, Animals, Binding Sites, Chickens, DNA, DNA-Binding Proteins, Lysine, Molecular Sequence Data, Nuclear Proteins, Protein Binding, Mass Spectrometry, Transcription Factors, Transcription, Genetic, Tumor Cells, Cultured, Trans-Activators, Zinc Fingers, 3T3 Cells, E1A-Associated p300 Protein, Erythroid-Specific DNA-Binding Factors, GATA1 Transcription Factor, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.